A PHASE III Open-Label Extension Study to Evaluate Long-termSafety and Efficacy Of PRM-151 In Patients with IdiopathicPulmonary Fibrosis (IPF)

Kim, Hyun J (PI)

Medicine - Pulmonary, Allergy, Critical

Project: Research project

Description

A PHASE III Open-Label Extension Study to Evaluate Long-term Safety and Efficacy Of PRM-151 In Patients with Idiopathic Pulmonary Fibrosis (IPF)

Status	Active
Effective start/end date	9/15/20 → 9/15/25

Funding

HOFFMANN-LA ROCHE PHARMACEUTICALS